NFE2L2 and hepatocellular carcinoma: According to recent research, the mitochondrial translocator protein (TSPO), which is involved in a broad range of mitochondrial functions, inhibits ferroptosis in HCC cells through the P62/KEAP1/NRF2 antioxidant pathway 83.